Company news

The last week of April is the World Immunization Week, which aims to promote vaccination and protect people of all ages from disease. Vaccination saves countless lives and is recognized as one of the most successful and cost-effective health interventions.

Point-of-care testing (POCT) is the rapid testing of biological samples (such as blood, urine, saliva, breath gas, etc.) at the patient's side, using simple instruments or reagents, and results can be obtained within minutes to hours. The test can help physicians make timely diagnosis and treatment plans, and provide important information to improve treatment outcomes in an emergency setting.

According to relevant data, the global market size of in vitro diagnostics in 2020 is $71.49 billion, and that of 2021 is $92.08 billion, which is expected to grow from $71.43 billion in 2022 to $107.42 billion in 2029, with a compound annual growth rate of 6% during the forecast period. During this period, the COVID-19 pandemic has increased the demand for in vitro diagnostics, and market participants have collectively witnessed a significant increase in sales and revenue from point-of-care tests.

Hemophilia is an inherited bleeding disorder disease caused by a deficiency of a certain clotting factor in one’s body. April 17 is designated as World Hemophilia Day every year in purpose to increase public awareness and attention to the hemophilia, express respect and support for hemophiliacs, and fight for the rights and interests for them.

According to the global cancer data of 2020, released by the International Agency for Research on Cancer (IARC) of the World Health Organization, China had 4.57 million new cases and 3 million deaths in 2020, ranking No.1 in the world. Lung cancer, colorectal cancer, stomach cancer, breast cancer and liver cancer are the most common cancers in China. According to statistics, one third of cancers can be prevented by keeping good living habits and early screening. "Early detection, early diagnosis and early treatment" might reduce the incidence and mortality of cancer, and save lives.

In order to raise people's awareness and attention to gastric cancer, as well as to provide convenient and fast detection services for the masses, WIZ cooperated with the Neighborhood Committee of Shuangdun Community, Beicheng New District, Hefei City, Anhui Province, to carry out a community public benefit activity for early screening of gastric cancer in Shuangdun Community, Beicheng New District, Hefei City, Anhui Province on March 20th.

These days, Xiamen WIZ Biotech Co., LTD. ("WIZ"), has been elected as the Vice President enterprise of the 4th Council of Xiamen Chamber of International Commerce. It is a great recognition to what we have achieved in the field of POCT so far, also a kind of support and encourage to us to continue to make more achievement in this field.